P4565Rivaroxaban treatment strategies reduce not only the first bleeding event, but all (including multiple) bleeding events: A PIONEER Substudy by Yee, M.K., Chi, G., Jain, P., Mehran, R., Bode, C., Halperin, J., Verheugt, F.W., Wildgoose, P., Korjian, S., Daaboul, Y., Lip, G.Y.H., Cohen, M., Peterson, E., Fox, K.A.A., Gibson, C.M.

Get full text

P4569Rivaroxaban treatment strategies reduce costs associated with rehospitalizations due to bleeding and cardiovascular events: results from the PIONEER AF-PCI trial by Pinto, D.S., Tamez, H., Korjian, S., Daaboul, Y., Mehran, R., Bode, C., Halperin, J., Verheugt, F.W., Wildgoose, P., Eickels, M., Lip, G.Y.H., Cohen, M., Peterson, E., Fox, K.A.A., Gibson, C.M.

Get full text

P6112Effect of procedure and lesion characteristics on bleeding and ischemic outcomes among atrial fibrillation patients undergoing percutaneous coronary intervention: results from... by Chi, G., Korjian, S., Daaboul, Y., Nafee, T., Mehran, R., Bode, C., Halperin, J., Verheugt, F.W., Wildgoose, P., Eickels, M., Lip, G.Y.H., Cohen, M., Peterson, E., Fox, K.A.A., Gibson, C.M.

Get full text

P3590Rivaroxaban strategies improve the number of days patients remain out of the hospital and event free: A PIONEER substudy by Gibson, C.M., Arbetter, D.F., Jain, P., Mehran, R., Bode, C., Halperin, J., Verheugt, F.W., Wildgoose, P., Eickels, M., Korjian, S., Daaboul, Y., Lip, G.Y.H., Cohen, M., Peterson, E., Fox, K.A.A.

Get full text